On April 18, 2025, Michael C. Greiner announced that he will leave Avanos Medical, Inc. (the “Company”) to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Warren J. Machan departed as Interim Chief Financial Officer at AVANOS MEDICAL, INC..
Action
no longer serves
Role
Interim Chief Financial Officer
Exact text from the filing
Mr. Machan no longer serves as the Company’s Interim Chief Financial Officer effective April 14, 2025
Michael C. Greiner departed as Senior Vice President and Chief Financial Officer at AVANOS MEDICAL, INC..
Action
leave
Role
Senior Vice President and Chief Financial Officer
Exact text from the filing
On April 18, 2025, Michael C. Greiner announced that he will leave Avanos Medical, Inc. (the “Company”) to pursue other opportunities because the Company did not offer him a position comparable to the one he held prior to his role as the Company’s Interim Chief Executive Officer.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.